Loading
Latest filing published 18 Oct 2023 for Thorne Healthtech, Inc., €49k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Thomas P. McKenna is a declared insider of Thorne Healthtech, Inc. (senior executive), with filings sourced from SEC (Form 4). Over a trading history stretching from 27 September 2021 to 16 October 2023, the count stands at 8 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 18 October 2023: a share grant of €49k, in Thorne Healthtech, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations